LANDOS BIOPHARMA INC (LABP)

US5150692011 - Common Stock

21.36  -0.2 (-0.93%)

Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to LABP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.1. This target is -76.12% below the current price.
LABP was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about LABP.
In the previous month the buy percentage consensus was at a similar level.
LABP was analyzed by 7 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 21.365.055.105.105.25 - -76.36% -76.12% -76.12% -75.42%
Up and Down Grades
Date Firm Action Rating
2023-01-06 Jefferies Downgrade Hold -> Underperform
2022-11-11 SVB Leerink Maintains Market Perform
2022-08-12 SVB Leerink Maintains Market Perform
2022-08-12 Raymond James Downgrade Outperform -> Market Perform
2022-04-12 Jefferies Downgrade Buy -> Hold
2022-01-03 JP Morgan Maintains Neutral
2021-11-16 SVB Leerink Downgrade Outperform -> Market Perform
2021-10-20 Craig-Hallum Initiate Buy
2021-10-19 HC Wainwright & Co. Initiate Buy
2021-09-23 JonesTrading Initiate Buy
2021-07-30 Raymond James Maintains Outperform
2021-03-01 SVB Leerink Initiate Outperform
2021-03-01 Raymond James Maintains Outperform
2021-03-01 JP Morgan Initiate Neutral
2021-03-01 Jefferies Initiate Buy